For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Ginkgo Bioworks Holdings Inc (NYSE: DNA) was $14.73 for the day, up 8.71% from the previous closing price of $13.55. In other words, the price has increased by $8.71 from its previous closing price. On the day, 2.87 million shares were traded. DNA stock price reached its highest trading level at $15.33 during the session, while it also had its lowest trading level at $13.94.
Ratios:
Our analysis of DNA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.79 and its Current Ratio is at 5.79. In the meantime, Its Debt-to-Equity ratio is 0.56 whereas as Long-Term Debt/Eq ratio is at 0.56.
Raymond James Downgraded its Outperform to Mkt Perform on November 14, 2023, whereas the target price for the stock was revised from $3.50 to $2.50.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 14 ’25 when Che Austin bought 99 shares for $14.00 per share.
Che Austin bought 99 shares of DNA for $1,255 on Feb 13 ’25. On Feb 12 ’25, another insider, Che Austin, who serves as the Officer of the company, bought 99 shares for $11.86 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DNA now has a Market Capitalization of 846664192 and an Enterprise Value of 611275840. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.68 while its Price-to-Book (P/B) ratio in mrq is 0.92. Its current Enterprise Value per Revenue stands at 2.805 whereas that against EBITDA is -1.281.
Stock Price History:
The Beta on a monthly basis for DNA is 1.17, which has changed by -0.7312044 over the last 52 weeks, in comparison to a change of 0.22894537 over the same period for the S&P500. Over the past 52 weeks, DNA has reached a high of $64.40, while it has fallen to a 52-week low of $5.26. The 50-Day Moving Average of the stock is 30.68%, while the 200-Day Moving Average is calculated to be 12.79%.
Shares Statistics:
DNA traded an average of 1.51M shares per day over the past three months and 2089300 shares per day over the past ten days. A total of 41.37M shares are outstanding, with a floating share count of 36.49M. Insiders hold about 33.02% of the company’s shares, while institutions hold 58.57% stake in the company. Shares short for DNA as of 1738281600 were 8253002 with a Short Ratio of 5.47, compared to 1735603200 on 7374291. Therefore, it implies a Short% of Shares Outstanding of 8253002 and a Short% of Float of 24.790001.
